Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

ANAPTYSBIO, INC — First Tracks Biotherapeutics, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / ANAPTYSBIO, INC

ANAPTYSBIO, INC

10% owner at First Tracks Biotherapeutics, Inc. · on record since Apr 1, 2026

Insider trading activity of ANAPTYSBIO, INC

Transactions on record: 1; since Apr 22, 2026

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Apr 22, 2026

Figures computed from official regulatory filings — methodology.

Companies where ANAPTYSBIO, INC has traded

First Tracks Biotherapeutics, Inc.1 tx · Apr 22, 2026

Track record of ANAPTYSBIO, INC

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of ANAPTYSBIO, INC

Co-insiders of ANAPTYSBIO, INC

EcoR1 Capital, LLCFirst Tracks Biotherapeutics, Inc.
Faga DanielFirst Tracks Biotherapeutics, Inc.
FENTON DENNIS MFirst Tracks Biotherapeutics, Inc.
Jain RitaFirst Tracks Biotherapeutics, Inc.
Lizzul Paul F.First Tracks Biotherapeutics, Inc.
Marquet MagdaFirst Tracks Biotherapeutics, Inc.
Orwin John AFirst Tracks Biotherapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Schmid John P.First Tracks Biotherapeutics, Inc.

STONE BENJAMINFirst Tracks Biotherapeutics, Inc.

Tamboli AjimFirst Tracks Biotherapeutics, Inc.

Ware J. AnthonyFirst Tracks Biotherapeutics, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
First Tracks Biotherapeutics, Inc.	Apr 22, 2026	Other	-100	—	—	SEC